drugset / Trial / NCT00257673
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine in a 12-week treatment study if MEM 1003 is a safe and effective treatment for patients with mild to moderate Alzheimer's disease.
Timeline
- Start
- 2005-11
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MEM 1003 | Small molecule | 30 mg | — |
| Subject | MEM 1003 | Small molecule | 90 mg | — |